Table 3 CAV3 mutations identified in patients affected by RMD
From: Caveolinopathies: from the biology of caveolin-3 to human diseases
Nt. change | Aa. change | Phenotype | Ref. |
|---|---|---|---|
N-terminal domain | |||
c.13InsG/c.114_453del | p.E4fs19X | RMD | Traverso et al46 |
c.77G>A | p.R26Q | RMD | |
c.82C>A | p.P28T | RMD | Van den Bergh et al74 |
c.133G>A | p.A45T | RMD | Betz et al66 |
c.134C>T | p.A45V | RMD | Betz et al66 |
c.136G>A | p.E46K | RMD | Kubisch et al72 |
c.140A>C | p.E46A | RMD | Lorenzoni et al71 |
Scaffolding domain | |||
c.154A>G | p.S52G | RMD | Dotti et al67 |
c.212C>A* | p.W70X | RMD | Ueyama et al45 |
Membrane-spanning domain | |||
c.257T>C* | p.L85P | RMD | Kubisch et al70 |
c.307_312del | p.F103_F104del | RMD | Bae et al69 |